“…A solution of the appropriate dihydropyridinone in degassed CH 2 Cl 2 (0.1 M) was irradiated with UV light at 365 nm (internal temperature within the UV chamber recorded as 30°C) 15 (1)), 141.1 (C(6)ArC (1)), 147.1 (C (6) (rac)-Ethyl anti-5-((4-nitrophenyl)sulfonyl)-2-oxo-3,6-diphenyl-1,2,3,4-tetrahydropyridine-4-carboxylate (10). Following the general procedure, irradiation of (rac)-ethyl anti-1-((4-nitrophenyl)sulfonyl)-2-oxo-3,6-diphenyl-1,2,3,4-tetrahydropyridine-4-carboxylate (50.7 mg, 0.1 mmol) in CH 2 Cl 2 (1.0 mL) for 18 h gave the crude product in >95 : 5 dr. Purification by column chromatography (CH 2 (3)), 126.9 (ArCH), 128.3 (C(6)ArC (1)), 128.6 (SO 2 ArC (2)), 128.7 (ArCH), 129.4 (ArCH), 131.1 (ArCH), 135.3 (C(3)ArC (1)), 146.6 (SO 2 ArC (1)), 148.3 (C(6)), 149.5 (SO 2 ArC (4) (rac)-Ethyl anti-5-(ethylsulfonyl)-2-oxo-3,6-diphenyl-1,2,3,4-tetrahydropyridine-4-carboxylate (12). Following a modified general procedure, irradiation of (rac)-ethyl anti-1-(ethylsulfonyl)-2-oxo-3,6-diphenyl-1,2,3,4-tetrahydropyridine-4-carboxylate (26 mg, 0.06 mmol) in CDCl 3 (1.0 mL) in an NMR tube for 24 h gave the crude product in 90 : 10 dr. Purification by column chromatography (hexane/EtOAc, 50 : 50) gave the title compound (20 mg (rac)-Ethyl anti-2-oxo-6-phenyl-5-( phenylsulfonyl)-3-(thiophen-3-yl)-1,2,3,4-tetrahydropyridine-4-carboxylate (13).…”